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Abstract
Aims/hypothesis High-fat, high-sucrose diet (HF)-induced re-
active oxygen species (ROS) levels are implicated in skeletal
muscle insulin resistance and mitochondrial dysfunction. Here
we investigated whether mitochondrial ROS sequestering can
circumvent HF-induced oxidative stress; we also determined
the impact of any reduced oxidative stress on muscle insulin
sensitivity and mitochondrial function.
Methods The Skulachev ion (plastoquinonyl decyltriphe-
nylphosphonium) (SkQ), a mitochondria-specific antiox-
idant, was used to target ROS production in C2C12
muscle cells as well as in HF-fed (16 weeks old) male
C57Bl/6 mice, compared with mice on low-fat chow
diet (LF) or HF alone. Oxidative stress was measured
as protein carbonylation levels. Glucose tolerance tests,
glucose uptake assays and insulin-stimulated signalling
were determined to assess muscle insulin sensitivity.
Mitochondrial function was determined by high-resolution
respirometry.
Results SkQ treatment reduced oxidative stress in muscle
cells (−23% p<0.05), but did not improve insulin sensi-
tivity and glucose uptake under insulin-resistant condi-
tions. In HF mice, oxidative stress was elevated (56% vs
LF p<0.05), an effect completely blunted by SkQ. How-
ever, HF and HF+SkQ mice displayed impaired glucose
tolerance (AUC HF up 33%, p<0.001; HF+SkQ up 22%;
p<0.01 vs LF) and disrupted skeletal muscle insulin
signalling. ROS sequestering did not improve mitochondrial
function.
Conclusions/interpretation SkQ treatment reduced muscle
mitochondrial ROS production and prevented HF-induced
oxidative stress. Nonetheless, whole-body glucose toler-
ance, insulin-stimulated glucose uptake, muscle insulin sig-
nalling and mitochondrial function were not improved.
These results suggest that HF-induced oxidative stress is
not a prerequisite for the development of muscle insulin
resistance.
Keywords Antioxidant treatment . High-fat high-sucrose
diet . Insulin resistance . Oxidative stress . Reactive oxygen
species . SkQ
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GPx1 Glutathione peroxidase 1
GSK3 Glycogen synthase kinase 3
HADH Hydroxylacyl dehydrogenase
HF High-fat, high-sucrose diet





ROS Reactive oxygen species
SkQ Skulachev ion (plastoquinonyl
decyltriphenylphosphonium)
SOD2 Superoxide dismutase 2
Introduction
Type 2 diabetes has been associated with oxidative stress, a
condition that arises when production of reactive oxygen
species (ROS) exceeds the antioxidant defence system’s
capacity. Several studies have shown that skeletal muscle
mitochondrial ROS production is increased in insulin-
resistant conditions [1, 2], which are an early hallmark in
the development of type 2 diabetes. Moreover, it has been
suggested that ROS and oxidative stress are causal factors of
skeletal muscle insulin resistance [3, 4].
Lee et al [5] recently showed that age-induced develop-
ment of insulin resistance, which is associated with
increases in ROS production and oxidative stress in mice,
could be prevented when mitochondrial H2O2 release was
attenuated by overexpression of the gene encoding mito-
chondrial catalase (MCAT), which also prevented the devel-
opment of mitochondrial dysfunction observed upon ageing.
Interestingly, type 2 diabetic patients also have mitochon-
drial dysfunction, as exemplified by smaller and damaged
mitochondria [6], reduced in vivo muscle ATP production
capacity [7, 8] and lowered mitochondrial density [9, 10].
Furthermore, we have previously demonstrated that ex vivo
intrinsic skeletal muscle mitochondrial respiration [11] and
in vivo mitochondrial oxidative capacity [8] are reduced in
patients with type 2 diabetes. Taken together, these findings
suggest that elevated ROS and oxidative stress in skeletal
muscle are implicated in insulin resistance and may be the
underlying cause of the mitochondrial dysfunction observed
in type 2 diabetes.
Therefore, we investigated whether the targeting of mi-
tochondrial ROS production in an in vitro and in vivo model
of lipid-induced insulin resistance could alleviate insulin
resistance by lowering muscle oxidative stress. For this
purpose, we used a novel oral mitochondria-specific antiox-
idant, the Skulachev ion (plastoquinonyl decyltriphenyl-
phosphonium) (SkQ). SkQ is a small cationic molecule
that targets and accumulates in the inner mitochondrial
membrane [12]. SkQ mainly scavenges superoxide radicals
arising from complex I, but can also sequester ROS gener-
ated from complex III [13], thus preventing excessive pro-
duction of mitochondria-generated ROS. In vitro studies
have shown that SkQ has a wide concentration range of
antioxidant capacity [13], and in vivo studies have demon-
strated that SkQ treatment effectively reduced oxidative
damage in several models of oxidative stress [12–14].
In the present study we used the SkQ compound to: (1)
determine whether sequestering of mitochondrial ROS pro-
duction can prevent increased ROS production and oxida-
tive stress in skeletal muscle under high-fat conditions; and
(2) examine the impact of the anticipated lowering of oxi-
dative stress on skeletal muscle insulin sensitivity and mi-
tochondrial function.
Methods
Chemicals SkQ was generously donated by O. Fedorkin
(Mitotech, Moscow, Russia). All other chemicals were pur-
chased from Sigma (St Louis, MO, USA) unless otherwise
stated.
C2C12 cell glucose uptake assay C2C12 cells (LGC stand-
ards, Teddington, UK) were maintained in DMEM (Glu-
taMAX low-glucose DMEM; Invitrogen, Breda, the
Netherlands) supplemented with 10% FCS (vol./vol.) and
grown on ECM (extracellular matrix) matrigel-coated cul-
ture plates. Cells were differentiated towards multinucleated
myotubes over the course of a week in αMEM supplemented
with 2% FCS (vol./vol.). Differentiated myotubes were pre-
treated with 20 nmol/l SkQ or vehicle (control) during the
last 3 days of differentiation before collection. For the oxi-
dative stress assay, myotubes were lysed in RIPA buffer and
protein carbonyls were determined as described below. Prior
to the glucose uptake assays, the cells were treated for 24 h
with 500 μmol/l palmitate conjugated to BSA (essential
NEFA-free) (ratio BSA:palmitate 1:2.5) or solely BSA (con-
trol). Deoxyglucose uptake was performed as previously
described [15].
In vivo mouse study Male C57Bl/6 mice (8 weeks old; n010
per group) were purchased from Charles River (Maastricht,
the Netherlands) and housed individually on a 12 h
light: 12 h dark cycle. The mice were placed on either
a low-fat chow diet (LF) (Ssniff, Soest, Germany) or a
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high-fat, high-sucrose diet (HF) (Research Diets, New
Brunswick, NJ, USA) for 16 weeks. A third group of
mice received the HF plus the SkQ antioxidant (HF+SkQ).
Based on previous studies, an SkQ dose of 250 nmol/kg body
weight [16] was supplemented throughout the study via the
drinking water [17]. Water bottles for all mice were refreshed
three times per week, and body weight and food intake were
measured weekly. After the 16 week dietary intervention
period, mice were fasted for 3 h and killed by cervical dislo-
cation under basal control (n05) conditions or after 10 min of
insulin (Actrapid; Novo Nordisk, Bagsvaerd, Denmark) stim-
ulation (10 U/kg i.p.; n05). Skeletal muscles were excised,
frozen in liquid nitrogen-cooled isopentane (2-methyl-butane;
Fluka, Zwijndrecht, the Netherlands) and stored at −80°C
until further analysis. All protocols were approved and con-
ducted in accordance with Maastricht University Animal
Ethics Committee guidelines.
Glucose tolerance tests and measurements from plasma Glu-
cose tolerance tests were performed after week 15 of the
intervention, following a 5 h fast as previously described
[18]. Blood glucose was measured using a glucose meter
(LifeScan, Milpitas, CA, USA) and samples were collected
in microtitre tubes (BD, Franklin Lakes, NJ, USA). Plasma
was separated by centrifugation for 5 min at 5,000 g and
stored at −80°C. Plasma insulin was measured using a
commercially available RIA kit (Millipore, Billerica, MA,
USA). Plasma triacylglycerol and NEFA levels were deter-
mined with commercially available kits from Roche (Schlie-
ren, Switzerland) and Wako Chemicals (Neuss, Germany),
respectively.
Western blot To determine (phosphorylated)Akt and oxida-
tive phosphorylation (OXPHOS) proteins, gastrocnemius
muscle was homogenised in lysis buffer (10% NP40 [vol./
vol.], 10% SDS [vol./vol.], 100 mmol/l PMSF in PBS) and
cells were lysed in RIPA buffer supplemented with protease
inhibitor cocktail (Roche). Equal amounts of protein were
loaded on to SDS-PAGE gel, and standard running, blocking
and incubation protocols were followed using primary anti-
bodies against Akt, phosphorylated Akt (pAkt) (S473) (Cell
Signaling Technology, Danvers, MA, USA), OXPHOS pro-
teins (Mitosciences, Eugene, OR, USA), sarcomeric actin
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) or
β-actin. The appropriate secondary antibodies (Invitrogen,
Paisley, UK) were applied and blots were visualised using
the Odyssey Near Infrared Imager (Licor, Leusden, the Nether-
lands) or with a maximum sensitivity substrate (SuperSignal
West Femto; Thermo Fisher Scientific, Waltham, MA, USA)
in a reader (ChemiDoc XRS; BioRad, Hercules, CA, USA).
For glycogen synthase kinase 3 (GSK3) and JUN N-terminal
kinase (JNK) phosphorylation, and IRS1 content levels, mus-
cle samples were homogenised in Bioplex lysis buffer
containing protease and phosphatase inhibitors (Biorad), after
which protein content was determined using a BCA-kit
(Thermo Scientific, Rockford, IL, USA). Protein (10 μg) was
loaded on to SDS-PAGE gels, and standard blocking and
incubation protocols were followed using primary antibodies
against phospho-GSK3α/β-Ser21/9 and phospho-JNK-
Thr183/Tyr185 (Cell Signaling Technology), or against IRS1
[19]. Loading corrections for phosphorylation levels were
performed by reprobing with antibodies recognising
α-tubulin (Calbiochem, Darmstadt, Germany) and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) (Cell Signaling
Technology). Bound antibodies were detected with
horseradish-peroxidase-conjugated secondary antibodies, fol-
lowed by enhanced chemiluminescence, and visualised using
the Versadoc system (Biorad). Blots were quantified using a
software package (Quantity One, version 4.6.9; Biorad). Pro-
tein carbonyl levels were assessed with a protein oxidation
detection kit (Oxyblot; Millipore) as described elsewhere [20].
Mitochondrial DNA copy number The mitochondrial DNA
copy number was determined by the ratio of Cox2 expres-
sion (mitochondrial gene) over Ucp2 expression (nuclear
gene) as previously described [21]. Briefly, isolated DNA
(Nucleospin Tissue kit; Macherey Nagel, Düren, Germany)
from gastrocnemius muscle samples was analysed by real-
time PCR using a sequence detector (ABI 7900; Applied
Biosystems, Branchburg, NJ, USA) and the following pro-
gram: one cycle at 50°C for 2 min then at 95°C for 10 min,
followed by 40 cycles at 95°C for 15 s and 60°C for 1 min.
The absolute quantification of each gene was determined by
a standard curve.
Enzyme activities The activity of superoxide dismutase 2
(SOD2) and glutathione peroxidase 1 (GPx1) was measured
in quadriceps muscle homogenates. SOD2 activity was de-
termined according to Oberley and Spitz [22] and distin-
guished from total SOD activity by pre-incubating the
samples with NaCN (5 mmol/l) for 30 min. GPx1 activity
was determined according to Paglia and Valentine [23] with
reduced glutathione at a concentration of 10 mmol/l. The
activity of hydroxylacyl dehydrogenase (HADH) and citrate
synthase (CS) was measured in gastrocnemius muscle
homogenates as previously described [24].
Mitochondrial isolation, respiration and ROS measurements In
a second set of mice (n07 per group) on the same diet
and intervention regimen as that described above, skeletal
muscle mitochondria were isolated and respiration was
measured as previously described [25, 26]. Respiration rates
in isolated mitochondria (0.1 mg/ml) were determined at 37°C
by polarographic oxygen sensors in a two-chamber Oxygraph
(Oroboros Instruments, Innsbruck, Austria) using pyruvate
(5 mmol/l) plus malate (3 mmol/l), or palmitoyl-coenzyme A
Diabetologia (2012) 55:2759–2768 2761
(CoA) (50 μmol/l) plus carnitine (2 mmol/l) as substrates. For
mitochondrial ROS production, we evaluated H2O2 release
from isolated mitochondria over 15min at 37°C using Amplex
Red fluorescence quantification (Invitrogen). Briefly, mito-
chondria (50 μg) were added to respiration buffer
(100 mmol/l sucrose, 50 mmol/l KCl, 20 mmol/l TES (2-
[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]etha-
nesulfonic acid), 1 mmol/l EDTA, 4 mmol/l KH2PO4, 2 mmol/
l MgCl2, 3 mmol/l malic acid and 0.1% [wt/vol.] fatty acid-free
BSA, pH 7.2) fuelled by succinate (10 mmol/l) in the presence
of complex III inhibitor antimycin (1 μmol/l) to maximise
ROS production [27]. The reaction started upon the addition
of Amplex Red reagent (100 μmol/l) and horseradish peroxi-
dase (2 U/ml). Superoxide dismutase (100 U/ml) was added to
the buffer to ensure complete conversion of superoxide to
H2O2 and to prevent the superoxide radical from interacting
with the horseradish peroxidase [28].
Statistics Results are expressed as means±SEM and were
analysed by one-way ANOVA followed by Newman–Keuls
post-hoc test, or by two-way ANOVA followed by Bonfer-
roni’s post-hoc test where appropriate. Basal and insulin-
stimulated conditions in muscle were analysed by two-tailed
Student’s t test. Significance was set at p<0.05. All graphs
and statistical analyses were performed using GraphPad
Prism 5.0 (GraphPad Software, San Diego, CA, USA).
Results
SkQ treatment does not improve palmitate-induced insulin
resistance in vitro SkQ treatment significantly lowered
oxidative stress by 23% (p<0.05) (Fig. 1a, b) as determined
by protein carbonyl content, a marker of oxidative damage, in
C2C12 myotubes under basal conditions. We investigated
whether this reduced level of oxidative stress affected cellular
glucose uptake under basal, insulin-stimulated and palmitate-
induced insulin-resistant conditions. Basal glucose uptakewas
similar between control and SkQ-treated myotubes (control
1.00±0.09, SkQ 0.94±0.06 arbitrary units [AU], n05–7,
p0NS). Insulin-stimulated glucose uptake was comparable
between control and SkQ-treated myotubes (Fig. 1c). The
incubation of C2C12 muscle cells with palmitate induced
insulin resistance, as seen in the significant reduction of glu-
cose uptake upon insulin stimulation in control and SkQ-
treated cells (p<0.001, two-way ANOVA). There was no
significant difference between palmitate-induced insulin resis-
tance in control and SkQ-treated myotubes (Fig. 1c). Further-
more, pAkt, a marker of insulin signalling, revealed
comparable results. Basal pAkt levels (control 0.22±0.06,
SkQ 0.18±0.04 AU, n08, p0NS) and insulin induction of
pAkt levels were similar in both cell groups (Fig. 1d). Palmi-
tate also reduced the insulin-stimulated pAkt response by about
half in control myotubes, a reduction not restored by SkQ
treatment (p<0.001, two-way ANOVA) (Fig. 1d). No signifi-
cant difference was seen in pAkt levels between control and
SkQ myotubes in the presence of palmitate. Total Akt levels
were comparable between control and SkQmyotubes under all
test conditions (Fig. 1d). Thus the SkQ-induced lowering of
oxidative stress did not suffice to ameliorate lipid-induced
insulin resistance in muscle cells.
SkQ treatment in vivo does not influence weight gain or
plasma lipid levels To extend our findings from the cell
model to the in vivo situation, we examined the effects
of SkQ treatment in mice. Male mice (8 weeks old) were
maintained on an LF or placed on an HF for 16 weeks. A
second group of HF-fed mice received drinking water
supplemented with SkQ (HF+SkQ). HF mice weighed
31% (p<0.0001) more than LF mice and had significantly
elevated NEFA, glucose and insulin levels (Table 1). The
HF+SkQ group also had significantly more weight gain
and elevated plasma values compared with LF controls,
with changes similar to those observed in HF mice. Food
intake was comparable in all three groups (Table 1), sug-
gesting no taste aversion to the SkQ treatment and normal
eating behaviour.
Fig. 1 ROS sequestering and insulin sensitivity in C2C12 cells.
(a) Oxyblot content and (b) representative blot in differentiated
C2C12 cells without (control [Ctrl]) or with SkQ treatment; n06 per
condition. Glucose uptake (c) in control (white bars) and SkQ-
pretreated (black bars) cells upon insulin stimulation in the absence
or presence of palmitate as indicated; n05–8 per condition. (d) pAkt
abundance under the same conditions as above (c), with representative
blot of pAkt, total Akt and actin (loading control) under basal, and
insulin- and palmitate-stimulated conditions. Data (a, c, d) are pre-
sented as mean±SEM; *p<0.05 and **p<0.01
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SkQ treatment reduces HF-induced oxidative damage Oxida-
tive stress measured as protein carbonyl content was increased
by 56% upon HF feeding (p<0.05 vs LF) (Fig. 2a, b). Consis-
tent with our findings in C2C12muscle cells, SkQ treatment in
vivo effectively prevented the diet-induced increase in skeletal
muscle oxidative damage (p<0.5 vs HF) (Fig. 2a, b). Since
SkQ specifically targets mitochondrial ROS production, we
also measured H2O2 release from freshly isolated skeletal
muscle mitochondria. H2O2 emission was significantly in-
creased in the HF group compared with LF (54%, p<0.05)
(Fig. 2c). SkQ treatment normalised H2O2 levels in HF+SkQ
mice to those of the LF controls (Fig. 2c), thus confirming the
efficacy of the mitochondrial-specific ROS scavenger as
shown above and previously reported [12–14]. In addition,
SOD2 (the mitochondrial SOD) activity was significantly
elevated in HF mice (twofold vs LF, p<0.01) (Fig. 2d),
suggesting a state of increased ROS production. SkQ
treatment significantly blunted the HF-induced increase
in SOD2 activity (p<0.05) (Fig. 2d). Finally, a trend was
observed for increased activity of the cytosolic antioxidant
GPx1 in both HF-fed groups (Table 1).
ROS sequestering does not improve insulin sensitivity Both
HF and HF+SkQ mice displayed exacerbated glucose metab-
olism compared with LF mice, as illustrated by decreased
glucose tolerance after 15 weeks of the intervention (Fig. 3a).
The AUC for glucose levels during the glucose tolerance test
was significantly increased by 33% (p<0.001) in HF and by
22% (p<0.01) in HF+SkQ mice (Fig. 3b). Insulin levels mea-
sured during the glucose tolerance test were also significantly
higher in both groups (Fig. 3c). Insulin AUC levels were
increased twofold (p<0.05) and fourfold (p<0.01) in HF and
HF+SkQ, respectively, compared with LF mice (Fig. 3d), in-
dicative of the hyperinsulinaemia associated with insulin resis-
tance. No statistical difference between HF and HF+SkQ mice
was observed for any of the variables mentioned above. In
addition, muscle-specific insulin signalling was evaluated by
examining levels of pAkt and its downstream target, phosphor-
ylated GSK3 (pGSK3), in gastrocnemius muscle under basal
and insulin-stimulated conditions (Fig. 4). Although insulin
significantly stimulated pAkt levels in LF, HF and HF+SkQ
mice (p<0.001, basal vs insulin) (Fig. 4a), the absolute increase
in insulin-stimulated pAkt was blunted in HF and HF+SkQ
mice (HF −35%, p<0.01; HF+SkQ −62%, p<0.001 compared
with LF). In addition, pGSK3 was significantly increased upon
insulin stimulation in LF mice (74% vs basal, p<0.05)
(Fig. 4b), while insulin signalling was severely disrupted in
HF and HF+SkQ mice, as there was no insulin-mediated
increase in pGSK3 over basal levels (p0NS) (Fig. 4b). Total
Akt was similar for all three groups under basal and insulin-
stimulated conditions (Fig. 4a); moreover, no change was
observed in IRS1 protein abundance (Fig. 4c). Phosphorylation
levels of JNK, an inflammation marker of insulin resistance,
were unaltered in all three groups (Fig. 4d), suggesting that HF
and HF+SkQ mice have disruptions in insulin signalling, with
no effect on inflammatory stress signalling.
The effect of ROS sequestering on mitochondrial content
and respiration Mitochondrial density was estimated by
mitochondrial DNA copy number, CS activity and the protein
Table 1 Body weight, plasma
values and skeletal muscle
enzyme activity




Variable LF HF HF+SkQ p value
Body weight (g) 27.6±0.4 40.1±1.2*** 40.3±1.3*** <0.0001
Food intake (kJ/week) 489.9±19.2 494.1±34.7 584.9±64.0 NS
Triacylglycerol (mmol/l) 1.99±0.30 2.67±0.12 2.94±0.34 0.07
NEFA (mmol/l) 0.53±0.09 1.24±0.15*** 1.30±0.06*** 0.0003
Glucose (mmol/l) 5.87±0.25 7.98±0.69** 8.13±0.33** 0.0027
Insulin (pmol/l) 61.2±14.3 218.7±28.9*** 212.1±20.5*** 0.0003
GPx1 activity (mU/mg) 5.83±0.37 7.01±0.37 6.65±0.24 0.07
HADH activity (U/mg) 38.54±6.57 62.07±8.31 63.47±9.37 0.07
Fig. 2 SkQ treatment effectively blunts HF-induced oxidative stress
and ROS production. (a) Quantification of muscle protein carbonyl in
LF, HF and HF+SkQ mice, with (b) a representative protein Oxyblot.
(c) Isolated mitochondria hydrogen peroxide production and (d) SOD2
activity assay in muscle homogenates. Data are presented as mean±
SEM; n07 per group for isolated mitochondrial assays and n05 per
group for activity and oxyblot assays; *p<0.05 vs LF, **p<0.01 vs LF
and †p<0.05 vs HF
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content of structural components of the respiratory chain
complexes (OXPHOS). Whereas no significant difference
was detected in the mitochondria DNA copy number
(Fig. 5a), CS activity was significantly increased in HF mice
(65%, p<0.01) (Fig. 5b) compared with LF. Similarly, the
OXPHOS complexes were increased in HF mice (57% vs LF,
p<0.01) (Fig. 5c, d). Interestingly, these HF-induced increases
in CS activity and OXPHOS content were normalised to LF
levels in HF+SkQ mice (Fig. 5b, c). Finally, we investigated
the impact of ROS sequestering on mitochondrial respiration,
fuelled by either a carbohydrate-derived (pyruvate) or a
fatty acid-derived (palmitoyl-CoA in the presence of
carnitine) substrate in isolated mitochondria (Table 2).
Under the HF condition, ADP-stimulated (state 3) pyruvate-
supported respiration rates tended to decrease (p00.06) com-
pared with LF mice. The maximum carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP)-induced (state U)
respiration, indicating the maximum capacity of the electron
transport chain on a given substrate, was significantly decreased
by 30% vs LF mice (p<0.05) (Table 2). At the same time,
there was no change in the oligomycin-insensitive (state 4)
respiration rate, a marker of mitochondrial proton leak. SkQ
supplementation did not restore the HF-induced reduction in
pyruvate-supported respiration, as HF+SkQ mice displayed
Fig. 3 ROS sequestering does
not improve glucose tolerance in
HF-fed mice. (a) Glucose toler-
ance curves after 15 weeks of
intervention in LF- (black
squares), HF- (black triangles)
and HF+SkQ-fed (white circles)
mice, with (b) AUC analysis in
groups as indicated. (c) Insulin
levels and (d) AUC during the
glucose tolerance test in the same
groups. Data are presented as
mean±SEM; n06–10 mice per
group; *p<0.05, **p<0.01 and
***p<0.001 vs LF. Two-way
ANOVA analysis revealed group
(p<0.0001) and time (p<0.0001)
effects for glucose, and a group
(p<0.0001) effect for insulin
during the glucose tolerance test
Fig. 4 Skeletal muscle insulin
signalling. (a) Basal control
(Bsl) and insulin-stimulated
(Ins) pAkt in LF (white bars),
HF (hatched bars) and HF+SkQ
(black bars) gastrocnemius
samples, with representative
pAkt, total Akt and actin (load-
ing control) blots. (b) Levels of
pGSK3, (c) total IRS1 content
and (d) pJNK in groups as
above (a). Data (a, c–e) are
presented as mean±SEM; n05
mice per group per condition;
*p<0.05 and ***p<0.001 for
basal vs insulin-stimulated
conditions
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similar decreases in pyruvate-supported state 3 and state U
(p<0.05) respiration rates. We did not observe any change in
fatty acid-supported mitochondrial respiration under ADP- or
maximal-stimulated conditions in any of the groups (Table 2).
Furthermore, skeletal muscle HADH activity (a beta-
oxidation enzyme) showed a tendency to be upregulated
under both high-fat conditions (Table 1).
Discussion
In the present study, we tested whether mitochondria-targeted
ROS sequestering (SkQ treatment) was able to preserve skel-
etal muscle insulin sensitivity in a muscle cell model of fatty
acid-induced and in a mouse model of diet-induced insulin
resistance. In vitro, SkQ treatment effectively reduced oxida-
tive stress in C2C12 myotubes, but did not improve glucose
uptake or insulin signalling under lipid-induced insulin resis-
tance. In vivo, SkQ treatment successfully normalised the
level of HF-induced oxidative stress in mouse muscle, but
this did not reverse the reduction in glucose tolerance and
skeletal muscle insulin sensitivity upon HF feeding.
Several studies have shown a link between insulin resis-
tance, ROS production and oxidative stress in in vitro and in
vivo models. Palmitate exposure in L6 myotubes resulted in a
dose-dependent decrease in insulin-mediated glucose uptake,
paralleled by increased superoxide production [29] and mito-
chondrial DNA damage [30]. In addition, cultured cells incu-
bated with H2O2 had greater insulin resistance [31], and ROS
production was identified as the common denominator and
causal factor in several cellular models of insulin resistance
[4]. Many studies have also reported beneficial effects on
insulin sensitivity when oxidative stress was blunted. As
mentioned previously, MCAT overabundance in mice im-
proved insulin sensitivity and attenuated H2O2 emission in
[5] ageing- and [1] high-fat diet-induced models of insulin
resistance. Similarly, rats treated with a small mitochondrial
antioxidant peptide were protected from high-fat diet-induced
mitochondrial H2O2 emission, impaired glucose uptake and
reduced skeletal muscle insulin sensitivity [1]. In contrast to
these studies [1, 5], we were unable to confirm that interfering
with mitochondrial ROS production, which leads to reduced
oxidative stress levels, averts HF-induced insulin resistance in
skeletal muscle. These discrepancies may be due to the tech-
nical approach used (genetic overexpression vs oral antioxi-
dant), the induction of oxidative stress (age- vs diet-induced)
and/or the duration of the intervention (6 vs 16 weeks). In
addition, the diet composition may also have led to differences
Fig. 5 Mitochondrial density markers. (a) Mitochondrial DNA copy
number, (b) gastrocnemius muscle CS activity, (c) total OXPHOS
complex quantification and (d) representative blots with sarcomeric
actin as loading control for mouse groups as shown. Data are presented
as mean±SEM; n05 for mtDNA and western blot and n010 for CS
assay; **p<0.01 vs LF and †p<0.05 vs HF
Table 2 Intrinsic mitochondrial respiration levels
Respiration pmol (s×mg)−1
Respiration state LF HF HF+SkQ p value
Pyruvate
State 3 5,356±441.3 3,928±515.1 3,680±481.2 0.0621
State 4 442.1±20.3 384.6±56.7 345.4±40.3 NS
State U 9,188±650.8 6,348±886.8* 6,436±771.3* 0.0291
Palmitoyl-CoA + carnitine
State 3 1,413±341.4 1,348±212.5 1,467±244.9 NS
State 4 446.9±40.1 392.2±40.5 395.0±36.5 NS
State U 1,781±472.4 1,654±285.5 1,859±331.8 NS
Values expressed as mean±SEM; n=6–7
ADP-stimulated (state 3) respiration was induced by the addition of ADP (450 μmol/l), state 4 respiration was attained upon addition of the ATP-
synthase inhibitor oligomycin (1 μg/ml) and maximum oxygen flux (state uncoupled, U) was achieved by titrating the chemical uncoupler FCCP
*p<0.05 vs LF
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between the studies. In the present study, we used a diet high
in fat and sucrose, which is known to induce oxidative stress,
mitochondrial dysfunction and insulin resistance [32]. This
may be relevant since the source of fat has been implicated as
a major contributor to lipid-induced ROS and insulin resis-
tance [30], but high sucrose levels also increase ROS produc-
tion and oxidative stress [33].
However, not all studies support the notion that ROS
production is a causal factor in insulin resistance. Thus it
has been shown that insulin stimulates the generation of
ROS, since when insulin binds to its receptor, a short burst
of cellular ROS is produced, acting as second messenger
that mediates insulin signalling [34, 35]. Furthermore, Loh
et al [36] demonstrated that subtle increases in ROS produc-
tion were in fact associated with improved insulin sensitivity
in mice deficient in the cytosolic antioxidant GPx1, suggest-
ing that ROS may even help enhance insulin sensitivity. At
the same time, overabundance of GPx1 resulted in hyper-
glycaemia, hyperinsulinaemia and insulin resistance in mice
[37], indicating that H2O2 quenching disrupts insulin action.
Moreover, Yokota et al [38] demonstrated that mice fed a
high-fat diet and treated with apocynin, an NAD(P)H oxi-
dase inhibitor, had blunted skeletal muscle superoxide pro-
duction, yet with no effect on glucose uptake or other
markers of insulin sensitivity. Finally, Abdul-Ghani et al
[39] failed to show a difference in skeletal muscle mito-
chondrial H2O2 levels between type 2 diabetic participants
and age-matched controls, suggesting that increased mito-
chondrial ROS is not a mediator of insulin resistance. Here,
we demonstrated, using a novel mitochondria-specific anti-
oxidant, that in vitro reductions of oxidative stress did not
avert lipid-induced disruptions of insulin-stimulated glucose
uptake and insulin signalling, although it remains possible
that palmitate exposure in these cells leads to insulin resis-
tance via mechanisms that are independent of oxidative
stress. On the other hand, in vivo whole-body glucose
tolerance, as well as insulin-mediated pAkt in skeletal mus-
cle remained impaired in mice on an HF supplemented with
SkQ, a mitochondria-targeted antioxidant, despite reduced
skeletal muscle oxidative stress. Although the slightly in-
creased insulin levels during the glucose tolerance test in our
HF+SkQ mice suggest that SkQ treatment causes an even
higher degree of HF-induced insulin resistance, this is not
supported by the muscle pAkt and in vitro glucose uptake
results. However, as we did not perform clamp studies, it is
possible that effects on skeletal muscle insulin-stimulated
glucose uptake in vivo remained undetected. Moreover,
alterations in muscle glucose transport subsequent to lipid-
induced insulin resistance may exist, regardless of an effect
on Akt signalling [40].
Bonnard et al [32] demonstrated that when mice were fed
a high-fat high-sucrose diet, similar to that used in the
present study, oxidative stress was coupled to reduced
mitochondrial biogenesis and dysfunction. In contrast, sev-
eral studies have observed upregulated mitochondria bio-
genesis in response to a high-fat insult [41, 42]; however,
this response seems to be dependent on the intervention time
[21, 25] and/or the method of determining mitochondrial
density [32]. In the present study, we measured several
markers of mitochondrial density, and observed that
OXPHOS content and CS activity revealed increased mito-
chondrial density in the HF-fed condition, in agreement with
previous reports [41]. Interestingly, these two markers were
normalised to LF levels upon ROS sequestering. This find-
ing is in line with other reports showing that antioxidant
supplementation suppresses exercise-induced mitochondrial
biogenesis [43, 44], suggesting a potential role of ROS in
mitochondrial biogenesis, although not all studies support
this conclusion [45].
We also observed a substrate-specific reduction upon
pyruvate (plus malate)-supported mitochondrial respiration.
These results are consistent with those of Mogensen et al
[46], who also demonstrated reduced pyruvate-supported
respiration rates with no change in lipid-supported respira-
tion rates in isolated muscle mitochondria from type 2
diabetes participants compared with age- and BMI-
matched controls. Thus SkQ treatment effectively reduced
skeletal muscle oxidative damage, but did not reverse the
HF-induced decrease in pyruvate-supported respiration.
Therefore we conclude that this reduction in pyruvate-
supported mitochondrial respiration does not occur as a
result of oxidative stress. It is tempting to speculate that
increased markers of mitochondrial content (OXPHOS pro-
teins and CS activity) in HF-fed mice may have compensat-
ed for the reduced intrinsic function. Since this response
appeared to be blunted in HF+SkQ mice, the latter are likely
to have had lower total mitochondrial oxidative capacity
than HF-fed mice, despite similar levels of insulin re-
sistance. These findings also argue against mitochondrial
dysfunction playing a causal role in the development of
HF-induced insulin resistance, which has been suggested
previously [6, 7].
A potential limitation of the present study is that only the
16 week endpoint variables were examined, making it im-
possible to comment on the favourable short-term effects of
antioxidant treatment on insulin sensitivity that have been
reported by others [47]. Nor can we exclude putative bene-
ficial effects of SkQ treatment upon prolonged exposure.
Furthermore, we only tested one dose. In this respect, other
studies have clearly shown the dose used by us to be optimal
in inbred and outbred rodents in longevity studies [16, 48].
However, it is possible that the full blockade of HF-induced
ROS production was too rigid, dissipating putative benefi-
cial effects of ROS, such as stimulation of endogenous
antioxidant capacity or mitochondrial biogenesis, which
themselves might in turn affect insulin sensitivity. Finally,
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oxidative stress is one of several putative mechanisms asso-
ciated with lipid-induced insulin resistance. If lipid-induced
insulin resistance is independent of increased ROS produc-
tion, then an intervention designed to suppress oxidative
stress clearly will not improve insulin sensitivity.
In conclusion, an antioxidant specific to the sequestering of
mitochondrial ROS production (SkQ) successfully suppressed
oxidative damage in vitro and under HF conditions in vivo.
Despite this relief of oxidative stress, SkQ treatment did not
ameliorate lipid-induced insulin resistance in the two study
models. Therefore, our results suggest that diet-induced oxi-
dative stress is not a prerequisite for the development of
skeletal muscle insulin resistance.
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